Skip to content
Homepage
Clinic directory

Clinics in Carmel, California

Every listing is checked against federal records, reviewed for evidence, and confirmed still operating. No pay-to-play. No guesswork.

  • No results found.
  • No results found.

Carmel, CA

Peptide Therapy clinics in Carmel

Carmel has a wealthy Indianapolis suburb with strong corporate and family demand, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across West Carmel, the Village of West Clay, and the Meridian corridor range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the IU Health North and Community North network. The scene here skews toward concierge clinics serving Indianapolis executives relocated to Hamilton County. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable Carmel clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.

1 Clinics

Regenerative Medicine of Carmel
MD on staff

Regenerative Medicine of Carmel

Carmel, CA

Regenerative Medicine of Carmel, a naturopathic practice in Carmel-by-the-Sea, specializes in integrative treatment of hormone imbalance and neurological function through a neuro-endocrinology lens. …

  • PRP Therapy
  • IV Therapy
  • Peptide Therapy
  • Hormone Replacement Therapy (HRT)
15 30 50 results per page

Regulatory context

A note on California's peptide therapy rules.

Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. In 2023 and 2024 the FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list, which restricts 503A compounding pharmacies from sourcing those ingredients for patient-specific prescriptions. Section 503A covers traditional pharmacies; Section 503B covers FDA-registered outsourcing facilities operating under cGMP.

  • California Business and Professions Code Division 2 Chapter 9 (Pharmacy Law)
    Governs compounding, licensure, and sourcing under the California State Board of Pharmacy.
  • California Code of Regulations Title 16 Section 1735 et seq.
    Sets compounding standards for sterile and non-sterile preparations.
  • California Business and Professions Code Section 2052
    Defines practice of medicine and limits who may prescribe or administer drugs.
  • California Naturopathic Doctors Act
    Grants licensed NDs limited prescriptive authority under formulary advisory committee rules.

The California State Board of Pharmacy inspects sterile compounding facilities under stringent state rules that often exceed USP 797. The Board has issued citations for sourcing non-compliant bulk ingredients and for office-use stocking that should have flowed through a 503B. Non-resident pharmacies shipping into California must hold a current non-resident permit; the Board publishes disciplinary actions and annual inspection findings. Clinics dispensing from in-office stock of compounded peptides are examined closely.

Sources: fda.gov · pharmacy.ca.gov · mbc.ca.gov · naturopathic.ca.gov

Peptide Therapy in Carmel, answered.

Carmel clinics most commonly offer sermorelin and sermorelin plus ipamorelin blends for growth hormone support, both of which are FDA-approved for adult GH deficiency. Healing peptides like BPC-157 and thymosin beta-4 (TB-500) are sometimes offered, but neither is FDA-approved and both landed on the FDA's Category 2 bulk list in 2023, which restricts compounding pharmacy sourcing. CJC-1295 and tesamorelin (Egrifta) appear in some protocols; tesamorelin is FDA-approved for HIV-associated lipodystrophy only. Melanotan II, epithalon, and selank are not FDA-approved.

$450 to $700 per month for sermorelin or sermorelin plus ipamorelin blends. $600 to $1,100 per month for BPC-157 plus TB-500 protocols when available through compounding. $550 to $950 per month for peptide plus hormone optimization bundles. Expect $400 to $900 upfront for initial labs (CBC, CMP, IGF-1, hormone panel, inflammatory markers) and the intake consult. Most clinics expect a 3 to 6 month commitment with monthly or quarterly follow-ups, and injection supplies and shipping from the compounding pharmacy are usually bundled into the monthly price.

Sermorelin and tesamorelin are FDA-approved for specific indications, so those are the only peptides a Indiana clinic can prescribe as standard practice with full FDA backing. BPC-157, CJC-1295, ipamorelin, thymosin beta-4 (TB-500), epithalon, melanotan, and most other research peptides are not FDA-approved. The FDA's 2023-2024 Category 2 bulk substances list decision meant 503A compounding pharmacies lost legal access to many of those ingredients, so availability fluctuates. Any Carmel clinic that still offers a long menu of non-approved peptides should disclose exactly where those ingredients come from.

Indiana is a reduced-practice state for nurse practitioners, meaning NPs operate under a collaborative agreement with a supervising physician. MDs and DOs can prescribe peptides directly, and NPs prescribe under that collaboration. All prescriptions must be filled through a state-licensed 503A compounding pharmacy. The Medical Licensing Board of Indiana licenses physicians and the Indiana Board of Pharmacy regulates compounding. Peptides are typically administered by subcutaneous injection at home after a training session at the clinic, though some Carmel offices offer in-clinic injections. Be wary of non-clinical operators selling peptides labeled as research chemicals, which is a federal red flag regardless of state law.

Verify the prescribing physician's active license through the Indiana medical board and confirm their NPI number through the NPPES registry. Ask which 503A compounding pharmacy supplies the peptides and whether that pharmacy is licensed in Indiana. Request baseline labs (CBC, CMP, IGF-1, hormone panel, inflammatory markers) before starting any growth hormone peptide, and confirm a monitoring schedule. Reputable Carmel clinics in West Carmel will clearly distinguish FDA-approved peptides from off-label compounds and avoid marketing research chemicals to the public.

Available here

Other Treatments available in Carmel

Explore statewide

Peptide Therapy in California

Filters

Rating

Treatments

Advanced Therapies 1
Chronic, Immune & Hormonal
Digestive & Respiratory
IV & Infusion
Pain & Musculoskeletal
Skin & Aesthetics
Mental Health & Neurology